Latest Post

March 1 represents Self-Injury Awareness Day (SIAD), an international awareness day that is dedicated to learning about behaviors like “cutting” and other intentional methods of self-injury —raising awareness and providing …

Zero Discrimination Day is an observance marked annually on March 1 by United Nations among other international organisations to promote equality and fairness before the law . The day was …

Summary : Peter Pitts, a former FDA associate commissioner and president of the Center for Medicine in the Public Interest, discusses the implications of Robert Califf’s appointment to lead the …

Summary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with uncontrolled epilepsy in England and Wales. The Final …

Summary : Vaccine pioneers expand presence throughout Europe with a view to leveraging technology The biotechnology company, Moderna, has announced plans to expand its commercial network across six additional countries …

Summary : British biotech company Scancell has expanded its research and development capabilities at one of the UK’s leading parks for science and technology companies – the Oxford Science Park …

Summary : Several FDA-approved drugs – including for type 2 diabetes, hepatitis C and HIV – significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human …

Summary : Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria In this Phase 3 trial, Dupixent added to standard-of-care antihistamines nearly doubled reduction in …

Summary : Capri EGM, an investment company specializing in corporate build-to-suit and sale leaseback financing and the acquisition of income-generating life science, R&D, and logistics real estate, has funded and …

Summary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) in response to its Biologics License …

Summary : New Syniverse CPaaS Platform to Accelerate Enterprises’ Digital Transformation and Improve Customer Experience The Syniverse Hyperscale Communications Platform allows enterprises to easily elevate their digital transformation to feature …

Synopsis : Pharma giants take major stride as vaccine shows significant increase in neutralising antibodies Sanofi and GlaxoSmithKline (GSK) have announced that they will submit data from both their booster …

Summary : The Committee for Medicinal Products for Human Use (CHMP) has provided an initial assessment of Valneva’s inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Following the company’s response, the European …

Summary : MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the combination of KEYTRUDA, Merck’s …

Summary : One of Eli Lilly’s diabetes drugs just scored another win with the U.S. Food and Drug Administration to expand its use in the heart failure population. Jardience will …

Summary: The U.S. Food and Drug Administration (FDA) has revised its emergency use authorization (EUA) for AstraZeneca’s Evusheld to a higher dose to be effective in the prevention of COVID-19. …

Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company appears to be making changes that will benefit its bottom line. AbbVie recently reported its …

Summary:  The U.S. Food and Drug Administration has approved the use of Purdue Pharma’s candidate injectable treatment for partially or completely reversing opioid drug effects. Nalmefene hydrochloride injection comes as …

Summary : Moderna only has a single marketed product, but it’s a blockbuster, for now at least. That product is the company’s mRNA vaccine against COVID-19, dubbed Spikevax. In today’s …

Summary : The success of mRNA vaccines against COVID-19 has become a cash cow for Moderna, the Pfizer and BioNTech team and Johnson & Johnson. All three companies earned an …

Summary : For years, researchers interested in treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have struggled to understand why variants of the gene encoding protein UNC13A, critical for …

Summary : Canada’s Medicago scored a regulatory first after Health Canada approved its plant-based COVID-19 vaccine Covifenz that has been paired with GlaxoSmithKline’s pandemic adjuvant as a preventative treatment against …

Summary : hC Bioscience, Inc., a company focused on discovering and developing tRNA-based therapies, announced that it has raised $24 million in Series A financing. The financing was led by …

Summary : LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study, “Treating Obstructive Sleep …

Summary : CANbridge Pharmaceuticals, Inc. (“CANbridge”, stock code 1228.HK), a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies, announced that CAN108 …

Summary : Alejandro Antalich, Chief Executive Officer and Director of Biomind Labs, said: “We are pleased to have obtained our DTC eligibility, complementing our recent listing approval on the OTCQB …

Synopsis : Kerry Group acquires majority of the shares of c-LEcta GmbH. The previous management of c-LEcta remains on board. Acquisition promotes c-LEcta’s growth potential and allows access to new …

Summary : Collaboration offers clinicians access to a state-of-the-art, cloud based oncology decision support platform that fully integrates the latest codified clinical content and generates patient specific treatment plans at …

Summary : Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) [TOKYO: 3002] is pleased to announce that Gunze has obtained medical device approval to manufacture and sell TENALEAF™, the first …

Summary : Topline data of the main cohort of AAVance clinical trial expected in Q3 2022 Stabilization or decreased size of white matter abnormalities observed at injection points for all …

Summary : Moderna is poised to begin Phase III of its pivotal clinical trial for its candidate vaccine for respiratory syncytial virus (RSV) in adults ages 60 years and up. …

Summary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab from the European Medicines Agency. Nirsevimab was greenlit to prevent medically attended lower respiratory tract …

Autoimmune diseases are triggered when the immune system malfunctions and attacks the body’s own structures. Although there is not, as yet, any cure for such diseases, their progression can be …

Summary – Takeda and Code Biotherapeutics announced a collaboration agreement to leverage the latter’s proprietary targeted 3DNA® non-viral genetic medicine delivery platform for the design and development of gene therapies …

Summary : Colombia became the latest country in Latin America to expand access to abortion Monday as the nation’s Constitutional Court voted to legalize the procedure until the 24th week …

Summary : Hong Kong will test its entire population for COVID-19 in March, the city’s leader said Tuesday, as the city grapples with its worst outbreak driven by the omicron …

Summary – Of course, Xiaomi is not far behind, they too have similar offerings (and they have smart shoes) and the latest in the line is their Performance T-Shirt. Xiaomi’s …

Summary : European Union countries agreed on Tuesday to open their borders to travellers from outside the bloc who have had shots against COVID-19 authorised by the World Health Organization, …

Synopsis : GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon. Haleon will …

Summary : A new study shows why certain NK cells are activated when encountering a cell infected with SARS-CoV-2. The infected cells contain a peptide from the virus that triggers …

Synopsis: Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and molecular diagnostics services. The acquisition, which aligns with …

Synopsis : Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to expand its commercial network across six additional countries in Europe. Moderna plans to …

Synopsis : ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global, multi-year definitive licensing agreement whereby it granted Eli …

Summary : Recipharm, a global contract development and manufacturing organisation (CDMO), is continuing to build its service offerings in new biologic modalities through the acquisition of Vibalogics, a virotherapy CDMO …

Synopsis : Recipharm, a leading global contract development and manufacturing organisation (CDMO), announced the acquisition of Arranta Bio, a prominent advanced therapy CDMO. Under the stewardship of Mark Bamforth and …

Summary – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Medigene AG (FSE: MDG1, Prime Standard, “Medigene”), a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, today announced that …

Summary : At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business …

Summary : Rare Disease Day has inspired a pioneering video to support patients living with rare conditions Alexion Pharma UK has launched a new video titled–‘Reforming Rare Diseases: Making the …

Synopsis : Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale of its portfolio company, Gyroscope Therapeutics Holdings plc. …

Summary : After a long wait, Bharat Biotech’s Covaxin has finally got the nod from the US Food and Drug Administration (USFDA) to conduct clinical trials in humans for its …